EBITDA Margin: Earnings before interest, taxes, depreciation and amortization as a portion of total revenue. Calculated as: EBITDA / Total Revenues
X4 Pharmaceuticals, Inc. (XFOR) EBITDA Margin data is not available.
| Income Statement Financials | |
$2.88M |
|
$-20.20M |
|
$0.51M |
|
$2.37M |
|
$22.87M |
|
$-19.99M |
|
$-0.20M |
|
$-20.20M |
|
$-20.20M |
|
$-20.20M |
|
$-20.20M |
|
$-20.20M |
|
$-20.20M |
|
$-19.99M |
|
$-19.66M |
|
126.52M |
|
126.52M |
|
$-0.16 |
|
$-0.16 |
|
| Balance Sheet Financials | |
$198.13M |
|
$0.06M |
|
$33.68M |
|
$231.82M |
|
$14.98M |
|
$77.01M |
|
$77.95M |
|
$92.93M |
|
$138.88M |
|
$108.71M |
|
$138.88M |
|
100.90M |
|
| Cash Flow Statement Financials | |
$-60.57M |
|
$29.25M |
|
$-0.04M |
|
$217.85M |
|
$186.48M |
|
$-31.38M |
|
$9.00M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
13.22 |
|
-- |
|
-- |
|
0.36 |
|
0.55 |
|
82.18% |
|
-694.37% |
|
-694.37% |
|
|
EBITDA Margin |
-- |
-701.46% |
|
-701.56% |
|
$-60.57M |
|
-- |
|
-- |
|
-- |
|
0.01 |
|
0.09 |
|
1.96 |
|
45.95 |
|
-14.54% |
|
-18.58% |
|
-8.71% |
|
-9.36% |
|
$1.38 |
|
$-0.48 |
|
$-0.48 |
|